ImClone regulatory update

IMCL received U.S. Patent No. 5,529,922 covering its BEC-2 therapeutic vaccine. BEC-2 is an anti-idiotypic monoclonal antibody designed to mimic GD3, a glycolipid (ganglioside) antigen found on the su...